Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma

Summary

This research study is studying a chemotherapy as a possible treatment for recurrent glioblastoma that has not responded to bevacizumab. The name of the study drug involved in this study is Ponatinib.

Timeline

Start

2015-07-13

Primary completion

2017-07-08

Completion

2018-05-09

Drugs

Indications